A computationally designed binding mode flip leads to a novel class of potent tri-vector cyclophilin inhibitors

dc.contributor.authorDe Simone, Alessio
dc.contributor.authorGeorgiou, Charis
dc.contributor.authorIoannidis, Harris
dc.contributor.authorGupta, Arun A.
dc.contributor.authorJuárez-Jiménez, Jordi
dc.contributor.authorDoughty-Shenton, Dahlia
dc.contributor.authorBlackburn, Elizabeth A.
dc.contributor.authorWear, Martin A.
dc.contributor.authorRichards, Jonathan P.
dc.contributor.authorBarlow, Paul N.
dc.contributor.authorCarragher, Neil
dc.contributor.authorWalkinshaw, Malcolm D.
dc.contributor.authorHulme, Alison N.
dc.contributor.authorMichel, Julien
dc.date.accessioned2021-07-29T07:58:20Z
dc.date.available2021-07-29T07:58:20Z
dc.date.issued2018-10-23
dc.date.updated2021-07-29T07:58:21Z
dc.description.abstractCyclophilins (Cyps) are a major family of drug targets that are challenging to prosecute with small molecules because the shallow nature and high degree of conservation of the active site across human isoforms offers limited opportunities for potent and selective inhibition. Herein a computational approach based on molecular dynamics simulations and free energy calculations was combined with biophysical assays and X-ray crystallography to explore a flip in the binding mode of a reported urea-based Cyp inhibitor. This approach enabled access to a distal pocket that is poorly conserved among key Cyp isoforms, and led to the discovery of a new family of sub-micromolar cell-active inhibitors that offer unprecedented opportunities for the development of next-generation drug therapies based on Cyp inhibition. The computational approach is applicable to a broad range of organic functional groups and could prove widely enabling in molecular design.
dc.format.extent6 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec700948
dc.identifier.issn2041-6520
dc.identifier.urihttps://hdl.handle.net/2445/179467
dc.language.isoeng
dc.publisherRoyal Society of Chemistry
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1039/C8SC03831G
dc.relation.ispartofChemical Science, 2018, vol. 10, p. 542-547
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/FP7/336289/EU//EBDD
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/655667/EU//ISOTRAPSS
dc.relation.urihttps://doi.org/10.1039/C8SC03831G
dc.rights(c) De Simone, Alessio et al., 2018
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)
dc.subject.classificationDianes farmacològiques
dc.subject.classificationDisseny de medicaments
dc.subject.classificationCompostos heterocíclics
dc.subject.classificationCompostos orgànics
dc.subject.otherDrug targeting
dc.subject.otherDrug design
dc.subject.otherHeterocyclic compounds
dc.subject.otherOrganic compounds
dc.titleA computationally designed binding mode flip leads to a novel class of potent tri-vector cyclophilin inhibitors
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
700948.pdf
Mida:
1.1 MB
Format:
Adobe Portable Document Format